Background. Various prospective studies have found that lean hypertensive patients have greater cardiovascular morbidity and mortality than obese hypertensive subjects. It was therefore hypothesized that hypertension is more benign when associated with obesity. In the present study, we evaluated effects of obesity on early target organ damage in patients with essential hypertension.
H ypertension and obesity are disorders that are closely linked.1-3 For many years, it has been well documented that obese patients are more likely to be hypertensive than lean individuals and that interim weight gain is predictive of later onset of hypertension.1'4 Both obesity and arterial hypertension have been identified as independent risk factors for cardiovascular disease in the Framingham Heart Study. [5] [6] [7] In the Honolulu Heart Program, rates of coronary heart disease and cardiovascular disorders were higher in obese than in nonobese men for both normotensive and hypertensive patients. 8 In a prospective follow-up of 8 years, the relative risk for fatal and nonfatal coronary heart disease increased from the lowest to the highest quintile of obesity in hypertensive women. 9 The absence of a protective effect in obesity hypertension is supported by a recent analysis of the Framingham Heart Study, in which the risk ratio for cardiovascular events was basically similar in lean and obese subjects.510 These studies are in contrast to several large-scale prospective studies that showed obese hypertensives to be at a lower risk of cardiovascular disease than lean hypertensivesl1-20 and therefore showed that obesity might exert "protective" effects on the cardiovascular system. In particular, in several studies in which the question of whether obesity attenuates the impact of high blood pressure on coronary arteries was addressed, prospective analysis revealed a lower risk for coronary heart disease in obese than in lean hypertensive subjects. 16, 17, 19, 20 It is difficult to explain the discordant results of the various studies. A recent review of 11 prospective studies suggested that the risk of major coronary artery diseaserelated events in lean hypertensive men was not as high as that in obese hypertensive men. 21 Ever since Perera and Damon22 reported that accelerated hypertension (defined by papilledema and biopsyverified arteriolar necrosis of kidney) is more prevalent in lean than in obese women but not men, the concept of the vascular protective effects of obesity in a subgroup of hypertensive patients has been controversial. No study has Hemodynamics Systemic and renal hemodynamics were assessed as previously described. 28 In brief, polyethylene tubing was introduced into an antecubital vein and into the brachial artery and advanced to the level of the superior vena cava and the ascending aorta, respectively. Continuous intra-arterial pressure was recorded, and mean arterial pressure was obtained by electrical integration. Cardiac output in the supine position was measured in triplicate using indocyanine green dye. Heart rate was measured by continuous ECG. Renal plasma flow was determined from the disappearance of a single injection of 131I para-aminohippuric acid, using the two-compartment model for calculations.28'3132 Stroke volume, total peripheral resistance, renal blood flow, renal blood supply (renal blood flow divided by cardiac output), and renal vascular resistance were calculated by standard formulas. The vascular compliance of large arteries was estimated by the stroke volume/pulse pressure index.33
Echocardiography
Left ventricular structure and function were evaluated by two-dimensionally guided M-mode echocardiography during or immediately after the invasive study. Echocardiographic tracings were recorded in the half left-sided position in the third or fourth interspace and analyzed by two independent observers according to the recommendations of the American Society of Echocardiography (ASE When compared with lean subjects, cardiac output was increased in the obese patients (p<0.001); this increase was observed in the normotensive and hypertensive groups ( Table 2 ). Elevated cardiac output was predominantly produced by increased stroke volume, noted in the obese patient groups (p<0.001), whereas heart rate was similar among lean and obese groups; again, these changes were independent of the level of arterial pressure, whether normotensive or hypertensive.
Conversely, total peripheral resistance was decreased in the obese groups (p<0.001) in comparison with their lean counterparts, regardless of whether they were normotensive or hypertensive ( Table 2) . Compliance of the large arteries, as judged by the stroke volume/pulse pressure index, was higher in the obese groups (p<O.OOl) than in the lean groups regardless of their level of arterial pressure. At a similar body mass index, hypertensive patients had a higher total peripheral resistance (p<0.001) and lower arterial compliance (p<0.02) than normotensive patients.
Renal plasma flow (p<0.06) and renal blood flow (p<0.05) were lower in hypertensive patients than in normotensive patients; conversely, renal vascular resistance was clearly elevated in established hypertension (p<0.01) ( Table 3 ). Obesity did not affect renal plasma flow, renal blood flow, or renal vascular resistance. Renal blood supply (renal blood flow divided by cardiac output) was found to be low in the hypertensive groups compared with the normotensive groups (p<0.01) predominantly because of the reduction in renal blood flow (p<0.05). Renal blood supply decreased even more in the presence of obesity (p<0.001) because cardiac output was elevated in both obese groups (Table 3) .
Left ventricular mass increased progressively with obesity and evidence of sustained hypertension ( their normotensive counterparts, and obesity appeared not to impair fractional fiber shortening or velocity of circumferential fiber shortening (Table 4) . Left ventricular stroke work, the product of stroke volume and systolic pressure, was most elevated in obese hypertensive patients (p<0.01) because of increased stroke volume related to obesity and because of increased systolic pressure in hypertension (Table 4) . To illustrate these results, total peripheral resistance and compliance of the large arteries, both of which are considered to reflect the severity of target organ damage in the systemic circulation, and renal vascular resistance and left ventricular mass were expressed as age-adjusted values in Figures 1-4 . Furthermore, obese subjects were subdivided into mildly obese (defined by body mass index >27 kg/m2 but <31 kg/m2) and severely obese patients (defined by body mass index exceeding 31 kg/m2). Total peripheral resistance (p<0.01) was higher and compliance of large arteries (p<0.05) was lower in the lean than in the mildly obese as well as the severely obese groups. This pattern was similar in the normotensive and hypertensive groups, although, of course, total peripheral resistance was elevated in sustained hypertension (p<0.01). Finally, to analyze the impact of obesity in various age, sex, and race groups, we calculated the ANCOVA in the specific subgroups (Tables 5-7 ). The presence of obesity resulted in a decrease in total peripheral resistance that was more pronounced in women than in men (for men, p<0.11; for women, p<0.001; Table 5 ), more in black than in white individuals, and more in old than in young subjects (allp<0.05). Renal vascular resistance was not influenced by obesity in various sex, race, and age groups (all not significant) in contrast to hypertension. As outlined above, the degree of left ventricular mass was increased in hypertension if obesity coexisted; however, this exaggeration held true only in the white (p<0.01) and male (p<0.01) subjects and in the young and old subjects, although only slightly (p<0.10), but not in the female or black subjects. Discussion Systemic vascular resistance is the hallmark of systemic vascular disease36-40 and was documented in a prospective study to be predictive for the development of cardiovascular morbidity and mortality along with age and left ventricular mass.40 In our current study in more than 200 participants, systemic vascular resistance was found to be lower in the obese groups than in their lean counterparts at similar levels of mean arterial pressure. The lower level of total peripheral resistance suggested that obese hypertensive patients were hemodynamically younger than their lean counterparts with regard to the systemic circulation. Conversely, we found that obesity hypertension (as opposed to hypertension in the nonobese) is hemodynamically characterized by an increased cardiac output, mainly due to a rise in stroke volume (which is produced via the Frank-Starling mechanism by an increased preload).41,42 Confirming our previous reports, [23] [24] [25] [26] [27] 41 these results indicate that the hemodynamic changes in obesity were already evident in subjects whose body mass index exceeded 27 kg/M2.
In hypertension, the vascular compliance of the large arteries was reduced, as indicated by a decreased stroke volume/pulse pressure index. 33 The presence of obesity appeared to counteract this process because this index was higher in obese than in lean normotensive subjects. This pattern was found in all subanalyses categorizing our patients -young versus old, black versus white, and male versus female patients. However, all hemodynamic profile measurements were determined at rest only and therefore do not represent the hemodynamic situation during daily life activities. [43] [44] [45] In two sets of experiments, we recently subjected lean and obese patients to stress and found that obese patients responded with an exaggerated blood pressure response mediated by an increase in total peripheral resistance.46 Thus, the seemingly protective hemodynamic effects of obesity observed at rest appeared to be blunted during exposure to stress. 46 This new observation in two different study groups clearly limits the interpretation of data determined at rest and questions their applicability for daily life situations.
In the current study, we did not observe any significant difference in renal blood flow and renal vascular resistance among the lean and obese groups regardless of whether the normotensive or hypertensive groups were compared, which is in contrast to a preliminary report that used analysis by matched pairs.47 Our current analysis, however, was based on a larger sample of patients and excluded any bias of age, sex, race, height, or mean arterial pressure by ANCOVA and specific subgroup analysis. In addition, a stepwise multiple regression analysis yielded no significant association between body mass index and renal hemodynamics, thereby confirming the current results. 48 The presence of hypertension, in contrast, clearly reduced renal blood flow and increased renal vascular resistance.49 Castleman and Smithwick50-51 reported that the more renal blood flow was reduced and vascular resistance elevated, the more severe was nephrosclerosis in renal biopsies of patients with essential hypertension. Thus, hypertension but not obesity impaired renal perfusion.
In our study, left ventricular mass was greatest in the obese hypertensive groups. This was particularly significant in white subjects and in men, but it was not found in black subjects and women. The latter appeared to be related to the relatively high left ventricular mass in the lean groups. Concomitantly, end-diastolic diameter was slightly enlarged, reflecting increased preload. Although we observed no impairment of cardiac performance, previous analysis noted a depressed myocardial contractility in patients with eccentric left ventricular hypertrophy of obesity.52 Recently, we reported peak filling rate, duration of peak filling rate, and left atrial emptying index (indicators of ventricular filling) to be reduced in obese normotensive and obese hypertensive patients in comparison with their lean counterparts.53 Depressed myocardial contractility and diastolic dysfunction, when sustained, will eventually lead to premature congestive heart failure, particularly in patients with obesity hypertension. [54] [55] [56] Unloading from the heart the double burden of obesity and hypertension by losing weight and controlling blood pressure should become a major goal of preventive cardiology. Although results from the four prospective studies examining the risks of obesity hypertension were controversial,8 0-12 a closer analysis favored the view that obesity in hypertensive patients is deleterious to the cardiovascular system. It appears that prospective studies might have been biased by the fact that lean subjects tended to have more rapid progression of hypertensive disease and earlier manifestations of cardiovascular complications than obese subjects. Consequently, when all patients with signs of cardiovascular disease at baseline were excluded (thereby also excluding lean hypertensive patients, who were more likely to die of cardiovascular complications), the socalled protective effects of obesity hypertension were no longer evident. Lean and obese hypertensive subjects had similar prognoses of the development of subsequent fatal cardiovascular events.8,10 However, the four prospective studies did not report statistical analysis of cardiovascular complications from cerebrovascular disease and end-stage renal disease.8,10-12 When looking at individual data, it appears that the risk for renal failure and cerebrovascular events was increased if obesity coexisted with hypertension.8 '10-12 In conclusion, obesity and arterial hypertension disparately affected structural and functional cardiovascular findings. Perfusion of the kidneys in hypertension was impaired to a similar extent in lean and obese hypertensive patients. Patients with obesity were hemodynamically younger than comparable lean subjects, at least during resting conditions. Left ventricular mass was found to be more markedly increased in obesity hypertension, a fact that indicates an additional risk for cardiovascular events. Thus, our analysis of early target organ damage in obesity hypertension does not support the concept that obesity exerts renoprotective or cardioprotective effects on the cardiovascular system. 
